Dr. Marc Matrana, MD
Claim this profileOchsner Medical Center Jefferson
Expert in Lung Cancer
Studies Thyroid Cancer
26 reported clinical trials
65 drugs studied
About Marc Matrana, MD
Education:
- Earned an MD from Louisiana State University School of Medicine, New Orleans, in 2007.
- Completed Residency in Internal Medicine at Ochsner Clinic Foundation in 2010.
- Completed Fellowship in Hematology/Oncology at Ochsner Clinic Foundation in 2013.
Experience:
- Assistant Professor of Medicine at the University of Queensland School of Medicine – Ochsner Clinical School.
- Director of the Alvin J. Blumkin Center for Innovation and Research in Lung Cancer at Ochsner Health.
- Specializes in lung cancer and thoracic oncology.
Area of expertise
1Lung Cancer
Global LeaderStage III
Stage IV
Stage II
2Thyroid Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Marc Matrana, MD is currently running
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Marc Matrana, MD
Clinical Trial Related5 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Marc Matrana, MD has experience with
- Pembrolizumab
- Nivolumab
- Ipilimumab
- Gemcitabine
- Gemcitabine Hydrochloride
- Docetaxel
Breakdown of trials Marc Matrana, MD has run
Lung Cancer
Thyroid Cancer
Non-Small Cell Lung Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marc Matrana, MD specialize in?
Marc Matrana, MD focuses on Lung Cancer and Thyroid Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Marc Matrana, MD currently recruiting for clinical trials?
Yes, Marc Matrana, MD is currently recruiting for 7 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Marc Matrana, MD has studied deeply?
Yes, Marc Matrana, MD has studied treatments such as Pembrolizumab, Nivolumab, Ipilimumab.
What is the best way to schedule an appointment with Marc Matrana, MD?
Apply for one of the trials that Marc Matrana, MD is conducting.
What is the office address of Marc Matrana, MD?
The office of Marc Matrana, MD is located at: Ochsner Medical Center Jefferson, New Orleans, Louisiana 70121 United States. This is the address for their practice at the Ochsner Medical Center Jefferson.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.